- Home
- FDUS vs MGTX Comparison
FDUS vs MGTX Comparison
Compare FDUS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDUS
- MGTX
- Stock Information
- Founded
- FDUS 2011
- MGTX 2015
- Country
- FDUS United States
- MGTX United States
- Employees
- FDUS N/A
- MGTX N/A
- Industry
- FDUS Finance/Investors Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FDUS Finance
- MGTX Health Care
- Exchange
- FDUS Nasdaq
- MGTX Nasdaq
- Market Cap
- FDUS 654.0M
- MGTX 670.2M
- IPO Year
- FDUS 2011
- MGTX N/A
- Fundamental
- Price
- FDUS $21.15
- MGTX $7.33
- Analyst Decision
- FDUS Buy
- MGTX Strong Buy
- Analyst Count
- FDUS 3
- MGTX 2
- Target Price
- FDUS $21.67
- MGTX $24.00
- AVG Volume (30 Days)
- FDUS 179.6K
- MGTX 284.2K
- Earning Date
- FDUS 10-30-2025
- MGTX 11-12-2025
- Dividend Yield
- FDUS 10.69%
- MGTX N/A
- EPS Growth
- FDUS N/A
- MGTX N/A
- EPS
- FDUS 2.31
- MGTX N/A
- Revenue
- FDUS $152,305,000.00
- MGTX $37,917,000.00
- Revenue This Year
- FDUS $5.41
- MGTX $145.67
- Revenue Next Year
- FDUS $5.98
- MGTX $167.61
- P/E Ratio
- FDUS $9.14
- MGTX N/A
- Revenue Growth
- FDUS 8.16
- MGTX 366.84
- 52 Week Low
- FDUS $16.70
- MGTX $3.94
- 52 Week High
- FDUS $23.55
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- FDUS 45.15
- MGTX 42.71
- Support Level
- FDUS $21.29
- MGTX $7.39
- Resistance Level
- FDUS $21.63
- MGTX $7.91
- Average True Range (ATR)
- FDUS 0.21
- MGTX 0.36
- MACD
- FDUS -0.03
- MGTX -0.00
- Stochastic Oscillator
- FDUS 7.14
- MGTX 19.89
About FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.